BCR and neoplasm: 99mTc-MIP-1404 PSMA-SPECT/CT was also shown to have high performance for detecting PSMA-positive lesions suggestive of tumor recurrence in patients with PCA BCR and very low serum PSA levels (Schmidkonz et al., 2019).